{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:08:39Z","timestamp":1791328119378,"version":"4.3.1"},"reference-count":42,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"DOI":"10.1210\/me.2011-1075","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T05:11:33Z","timestamp":1317964293000},"page":"1880-1891","source":"Crossref","is-referenced-by-count":21,"title":["CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation"],"prefix":"10.1210","volume":"25","author":[{"given":"Yunguang","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Medicine (Y.T., J.M., H.F., S.-G.R., H.P.K., S.M.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics (J.Z.), Harvard School of Public Health, Harvard University, Boston, Massachusetts 02446"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Medicine (Y.T., J.M., H.F., S.-G.R., H.P.K., S.M.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Department of Medicine (Y.T., J.M., H.F., S.-G.R., H.P.K., S.M.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Guang","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Medicine (Y.T., J.M., H.F., S.-G.R., H.P.K., S.M.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Gutierrez-Hartmann","sequence":"additional","affiliation":[{"name":"Departments of Medicine and of Biochemistry & Molecular Genetics (A.G.-H.), University of Colorado, Anschutz Medical Campus, Denver, Colorado 80045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Phillip","family":"Koeffler","sequence":"additional","affiliation":[{"name":"Department of Medicine (Y.T., J.M., H.F., S.-G.R., H.P.K., S.M.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[{"name":"Department of Medicine (Y.T., J.M., H.F., S.-G.R., H.P.K., S.M.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041123593082800_B1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123593082800_B2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02899695","article-title":"Pituitary lactotrophs and somatotrophs in pregnancy: a correlative in situ hybridization and immunocytochemical study.","volume":"62","author":"Stefaneanu","year":"1992","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"2019041123593082800_B3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1677\/joe.0.1110367","article-title":"Regression of redundant lactotrophs in rat pituitary gland after cessation of lactation.","volume":"111","author":"Haggi","year":"1986","journal-title":"J Endocrinol"},{"key":"2019041123593082800_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","article-title":"What can we learn from rodents about prolactin in humans?","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocr Rev"},{"key":"2019041123593082800_B5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.290.5494.1127","article-title":"Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification.","volume":"290","author":"Scully","year":"2000","journal-title":"Science"},{"key":"2019041123593082800_B6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000094310","article-title":"Molecular mechanisms of pituitary differentiation and regulation: implications for hormone deficiencies and hormone resistance syndromes.","volume":"35","author":"Drouin","year":"2006","journal-title":"Front Horm Res"},{"key":"2019041123593082800_B7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2010.10.014","article-title":"Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency.","volume":"25","author":"Pf\u00e4ffle","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2019041123593082800_B8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/mend.13.6.0298","article-title":"Regulation of estrogen receptor activation of the prolactin enhancer\/promoter by antagonistic activation function-2-interacting proteins.","volume":"13","author":"Schaufele","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041123593082800_B9","doi-asserted-by":"crossref","first-page":"39684","DOI":"10.1074\/jbc.M302433200","article-title":"Ras signaling and transcriptional synergy at a flexible Ets-1\/Pit-1 composite DNA element is defined by the assembly of selective activation domains.","volume":"278","author":"Duval","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041123593082800_B10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/nar\/29.5.1251","article-title":"Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.","volume":"29","author":"Schweppe","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2019041123593082800_B11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000094307","article-title":"Genesis of prolactinomas: studies using estrogen-treated animals.","volume":"35","author":"Sarkar","year":"2006","journal-title":"Front Horm Res"},{"key":"2019041123593082800_B12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/15275","article-title":"Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.","volume":"5","author":"Heaney","year":"1999","journal-title":"Nat Med"},{"key":"2019041123593082800_B13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1113\/expphysiol.2010.054502","article-title":"Epidermal growth factor induces a sexually dimorphic proliferative response of lactotroph cells through PKC\/ERK1\/2\/Pit-1 in vitro.","volume":"96","author":"De Paul","year":"2011","journal-title":"Exp Physiol"},{"key":"2019041123593082800_B14","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1158\/0008-5472.CAN-08-0508","article-title":"Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.","volume":"68","author":"Vlotides","year":"2008","journal-title":"Cancer Res"},{"key":"2019041123593082800_B15","doi-asserted-by":"crossref","first-page":"e18097","DOI":"10.1371\/journal.pone.0018097","article-title":"Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor.","volume":"6","author":"Radl","year":"2011","journal-title":"PLoS One"},{"key":"2019041123593082800_B16","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1210\/en.2007-0378","article-title":"Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.","volume":"148","author":"Gruszka","year":"2007","journal-title":"Endocrinology"},{"key":"2019041123593082800_B17","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1210\/endo.140.6.6757","article-title":"Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant mendelian inheritance of the ACI phenotype.","volume":"140","author":"Spady","year":"1999","journal-title":"Endocrinology"},{"key":"2019041123593082800_B18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11102-007-0082-2","article-title":"Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses.","volume":"11","author":"Evans","year":"2008","journal-title":"Pituitary"},{"key":"2019041123593082800_B19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.onc.1208393","article-title":"C\/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.","volume":"24","author":"Gery","year":"2005","journal-title":"Oncogene"},{"key":"2019041123593082800_B20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors.","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2019041123593082800_B21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation.","volume":"365","author":"Ramji","year":"2002","journal-title":"Biochem J"},{"key":"2019041123593082800_B22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0378-1119(94)90819-2","article-title":"Transactivation of the \u2018promoterless\u2019 luciferase-encoding vectors pXP1 and pXP2 by C\/EBP \u03b1.","volume":"138","author":"Li","year":"1994","journal-title":"Gene"},{"key":"2019041123593082800_B23","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1158\/0008-5472.CAN-03-3619","article-title":"CCAAT\/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.","volume":"65","author":"Ikezoe","year":"2005","journal-title":"Cancer Res"},{"key":"2019041123593082800_B24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/jcb.20223","article-title":"CCAAT\/Enhancer binding protein \u03b4 (c\/EBP\u03b4) regulation and expression in human mammary epithelial cells. I. \u201cLoss of function\u201d alterations in the c\/EBP\u03b4 growth inhibitory pathway in breast cancer cell lines.","volume":"93","author":"Sivko","year":"2004","journal-title":"J Cell Biochem"},{"key":"2019041123593082800_B25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/eji.1830230428","article-title":"The transcription factor Pit-1\/GHF-1 is expressed in hemopoietic and lymphoid tissues.","volume":"23","author":"Delhase","year":"1993","journal-title":"Eur J Immunol"},{"key":"2019041123593082800_B26","first-page":"2021","article-title":"Expression of pit-1 messenger ribonucleic acid and protein in the human placenta.","volume":"80","author":"Bamberger","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123593082800_B27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/joe.0.1730161","article-title":"Pit-1\/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line.","volume":"173","author":"Gil-Puig","year":"2002","journal-title":"J Endocrinol"},{"key":"2019041123593082800_B28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/eje.1.01962","article-title":"Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation.","volume":"153","author":"Gil-Puig","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2019041123593082800_B29","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1158\/0008-5472.CAN-06-1451","article-title":"Functional interaction of the retinoblastoma and Ini1\/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis.","volume":"66","author":"Guidi","year":"2006","journal-title":"Cancer Res"},{"key":"2019041123593082800_B30","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/MCB.25.7.2660-2672.2005","article-title":"Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland.","volume":"25","author":"Lazzerini Denchi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2019041123593082800_B31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000094316","article-title":"Gene therapy in the neuroendocrine system.","volume":"35","author":"Here\u00f1\u00fa","year":"2006","journal-title":"Front Horm Res"},{"key":"2019041123593082800_B32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/359295a0","article-title":"Effects of an Rb mutation in the mouse.","volume":"359","author":"Jacks","year":"1992","journal-title":"Nature"},{"key":"2019041123593082800_B33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jcp.21791","article-title":"Nuclear cyclin D1: an oncogenic driver in human cancer.","volume":"220","author":"Kim","year":"2009","journal-title":"J Cell Physiol"},{"key":"2019041123593082800_B34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4161\/cc.6.12.4409","article-title":"Two distinct controls of mitotic cdk1\/cyclin B1 activity requisite for cell growth prior to cell division.","volume":"6","author":"Miyazaki","year":"2007","journal-title":"Cell Cycle"},{"key":"2019041123593082800_B35","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1091\/mbc.e10-05-0393","article-title":"The roles of cyclin A2, B1, and B2 in early and late mitotic events.","volume":"21","author":"Gong","year":"2010","journal-title":"Mol Biol Cell"},{"key":"2019041123593082800_B36","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/MCB.15.5.2849","article-title":"Functional interaction of c-Ets-1 and GHF-1\/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain.","volume":"15","author":"Bradford","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2019041123593082800_B37","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1038\/sj.onc.1208501","article-title":"Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone\/prolactin cell pituitary adenomas and natural killer cell lymphomas.","volume":"24","author":"Fedele","year":"2005","journal-title":"Oncogene"},{"key":"2019041123593082800_B38","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/sj.onc.1205428","article-title":"Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.","volume":"21","author":"Fedele","year":"2002","journal-title":"Oncogene"},{"key":"2019041123593082800_B39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-1028-1-17","article-title":"E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression.","volume":"1","author":"Fedele","year":"2006","journal-title":"Cell Div"},{"key":"2019041123593082800_B40","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-08-4133","article-title":"HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.","volume":"69","author":"De Martino","year":"2009","journal-title":"Cancer Res"},{"key":"2019041123593082800_B41","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1534\/genetics.104.039370","article-title":"Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.","volume":"169","author":"Strecker","year":"2005","journal-title":"Genetics"},{"key":"2019041123593082800_B42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00309499","article-title":"A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors.","volume":"23","author":"Imaizumi","year":"1993","journal-title":"Surg Today"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/25\/11\/1880\/8928991\/mend1880.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T18:54:38Z","timestamp":1555095278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/25\/11\/1880\/2614760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2011-1075","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}